Advanced Medical Solutions Group Regulatory News (AMS)

12 Dec 2006 07:00

Advanced Medical Solutions Grp PLC12 December 2006 For immediate release 12 December 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") Trading Update Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, today announces an update on current trading priorto its close period for the year to 31 December 2006. The Company's preliminaryresults will be announced in March 2007. Dr. Geoffrey Vernon, Chairman of Advanced Medical Solutions Group plc, stated: "The expected excellent progress has been delivered during the second half ofthe year and I am therefore pleased to report that the resultant cash generationand profitability mean that the Company is trading at the top end of marketexpectations. "This is a very exciting time for AMS. Our organic business continues to performwell across key products and geographies. We are seeing the widening acceptanceof our ActivHeal(R) woundcare range by NHS Trusts in the UK, we have broadenedour presence in the dynamic global silver alginate market, and successfulregulatory submissions to the FDA have increased our access to the lucrative USmarket for our tissue adhesives and sealants technology. "Also, the move to profitability and strong cash position is allowing managementto consider suitable bolt-on acquisitions to leverage AMS' technology anddistribution base." -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock Exchange